Diagenode Announces Acquisition of Service Provider NXT-Dx to Complement Epigenetics Assay Services
Monday, August 20, 2018 New acquisition rounds out Diagenode’s epigenomics profiling services platform DENVILLE, N.J. AND LIEGE, BELGIUM (PRWEB) AUGUST 16, 2018 Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider based in Gent, Belgium. NXT-Dx provides a broad variety of start-to-finish epigenetics services including a number of targeted DNA methylation assays using... Read more